ASKA Pharmaceutical Holdings Co Ltd
TSE:4886

Watchlist Manager
ASKA Pharmaceutical Holdings Co Ltd Logo
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Watchlist
Price: 2 306 JPY 2.04% Market Closed
Updated: May 23, 2024

ASKA Pharmaceutical Holdings Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ASKA Pharmaceutical Holdings Co Ltd
Cost of Revenue Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Cost of Revenue
-¥32.2B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Cost of Revenue
-¥1.4T
CAGR 3-Years
-13%
CAGR 5-Years
-17%
CAGR 10-Years
-11%
Daiichi Sankyo Co Ltd
TSE:4568
Cost of Revenue
-¥415.3B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Otsuka Holdings Co Ltd
TSE:4578
Cost of Revenue
-¥626.2B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
-4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cost of Revenue
-¥334.9B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Astellas Pharma Inc
TSE:4503
Cost of Revenue
-¥292.5B
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
1%

See Also

What is ASKA Pharmaceutical Holdings Co Ltd's Cost of Revenue?
Cost of Revenue
-32.2B JPY

Based on the financial report for Mar 31, 2024, ASKA Pharmaceutical Holdings Co Ltd's Cost of Revenue amounts to -32.2B JPY.

What is ASKA Pharmaceutical Holdings Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-3%

Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for ASKA Pharmaceutical Holdings Co Ltd have been -3% over the past three years , -3% over the past five years .